METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN GENERAL POPULATION IN MEXICO: PREVALENCE, CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS

被引：0
|
作者：
Cervera, Luis A. Chi
Remes-Troche, Jose Maria
Reyes, Raul Bernal
Amieva-Balmori, Mercedes
Parra, Bryan Adrian Priego
Rodriguez, Leonardo A. Martinez
Vazquez, Sophia E. Martinez
Mendez-Guerrero, Osvely
Chavez, Maria E. Icaza
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su376
引用
收藏
页码：S672 / S672
页数：1
相关论文
共 50 条
  • [1] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    [J]. LIVERS, 2023, 3 (04): : 597 - 617
  • [2] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [3] Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children
    Rupasinghe, Kushila
    Hind, Jonathan
    Hegarty, Robert
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 583 - 591
  • [4] Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
    Barchetta, Ilaria
    Cimini, Flavia Agata
    Cavallo, Maria Gisella
    [J]. NUTRIENTS, 2020, 12 (11) : 1 - 14
  • [5] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation
    Carnagarin, Revathy
    Tan, Kearney
    Adams, Leon
    Matthews, Vance B.
    Kiuchi, Marcio G.
    Marisol Lugo Gavidia, Leslie
    Lambert, Gavin W.
    Lambert, Elisabeth A.
    Herat, Lakshini Y.
    Schlaich, Markus P.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [6] Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Prasoppokakorn, Thaninee
    Pitisuttithum, Panyavee
    Treeprasertsuk, Sombat
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 939 - 946
  • [7] FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
    Gu, Zhan
    Bi, Yan
    Yuan, Fan
    Wang, Ruirui
    Li, Dong
    Wang, Jianying
    Hu, Xiaojuan
    He, Guang
    Zhang, Lei
    Liu, Bao-cheng
    [J]. CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 1333 - 1341
  • [8] Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
    Sangro, Paloma
    de la Torre Alaez, Manuel
    Sangro, Bruno
    D'Avola, Delia
    [J]. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 79 (04) : 869 - 879
  • [9] The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD)
    Wang, Qianzhuo
    Zhang, Yingjuan
    Lu, Ruiling
    Zhao, Qingwen
    Gao, Yue
    [J]. FITOTERAPIA, 2024, 178
  • [10] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality
    Semmler, Georg
    Wernly, Sarah
    Bachmayer, Sebastian
    Leitner, Isabella
    Wernly, Bernhard
    Egger, Matthias
    Schwenoha, Lena
    Datz, Leonora
    Balcar, Lorenz
    Semmler, Marie
    Stickel, Felix
    Niederseer, David
    Aigner, Elmar
    Datz, Christian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : 2670 - 2677
12345